Quarter-dose (0.025 mmol/kg) gadobenate dimeglumine for abdominal MRI in patients at risk for nephrogenic systemic fibrosis: preliminary observations.

@article{Campos2011QuarterdoseM,
  title={Quarter-dose (0.025 mmol/kg) gadobenate dimeglumine for abdominal MRI in patients at risk for nephrogenic systemic fibrosis: preliminary observations.},
  author={Rafael Olinto Pelaez de Campos and V. Beltran Heredia and Miguel Ramalho and Marcos S De Toni and Caroline Ziemer and Edwin Robert Fuller and R C Semelka},
  journal={AJR. American journal of roentgenology},
  year={2011},
  volume={196 3},
  pages={
          545-52
        }
}
OBJECTIVE The purpose of this study is to evaluate the feasibility of 0.025 mmol/kg gadobenate dimeglumine, which is one quarter of the standard dose, for abdominal 3-T MRI studies in patients considered to be at risk for nephrogenic systemic fibrosis, using qualitative and quantitative measures and comparison with higher doses. MATERIALS AND METHODS The MRI database was retrospectively searched to select consecutive patients who underwent quarter-dose gadobenate dimeglumine-enhanced… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-8 OF 8 CITATIONS

Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance

  • Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
  • 2012
VIEW 1 EXCERPT
CITES METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 35 REFERENCES

ACR guidance document for safe MR practices: 2007.

  • AJR. American journal of roentgenology
  • 2007
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Nephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices.

  • Clinical journal of the American Society of Nephrology : CJASN
  • 2010
VIEW 2 EXCERPTS

VassarStats: Website for statistical computation.faculty.vassar.edu/lowry/VassarStats

R. Lowry
  • html. Accessed June
  • 2010
VIEW 1 EXCERPT

Evaluation of the incidence of nephrogenic systemic fibrosis in patients with moderate renal insufficiency administered gadobenate dimeglumine for MRI

BJ Bryant
  • Clin Radiol
  • 2009